Dengue Infection Complicated by Hyperinflammatory Condition
|
By LabMedica International staff writers Posted on 11 Jul 2019 |
|
Image: A bone marrow aspirate from a patient suffering from Hemophagocytic Lymphohistiocytosis showing a macrophage that has ingested a nucleated red cell (Photo courtesy of UF).
The global incidence of dengue infection has grown dramatically and been estimated to 390 million infections yearly. This mosquito-borne virus infection occasionally develops into a potentially lethal state called severe dengue (SD).
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition that comes in primary (genetic) and secondary (acquired) forms. The most common causes of secondary HLH (sHLH) are infections, neoplasms, and autoimmune diseases; the most common infection-associated HLH is caused by Epstein-Barr virus (EBV-HLH).
Medical scientists from Hospital Sultanah Aminah (Johor, Malaysia) working with their Swedish colleagues, carried out a 5-year retrospective single-center study on all adult patients with SD admitted to a tertiary intensive care unit (ICU). The team reported that 39/180 (22%) patients with SD died, and 21/180 (12%) had HLH defined as HLH-probability ≥70% according to HScore; nine (43%) died. Similarly, 12/31 (39%) fulfilling ≥4 and 7/9 (78%) fulfilling ≥5 HLH-2004 diagnostic criteria died.
Peak values of AST, ALT, LDH, and creatinine correlated to fatality (Odds Ratio (OR) =2.9, 3.4, 5.8, and 31.9, respectively), as did peak ferritin (OR=2.5, nadir platelets (OR=1.9); hepatomegaly (OR=2.9), and increasing age (OR=1.2), The median peak AST, ALT, and LDH levels for the 180 patients were 510 U/L (range 22-35,427), 246 U/L (12-8,330), and 1,203 U/L (249-21,591), respectively. Multivariable logistic regression revealed peak AST (OR=2.8), peak creatinine (OR=7.3), and SOFA score (OR=1.4), as independent risk factors of death.
The authors concluded that it is important to be aware of dengue-HLH in SD due to its high mortality. They recommend a prospective study is needed in patients with, or at high risk of developing, dengue-HLH to evaluate prompt HLH-directed therapy with corticosteroids as dexamethasone, and in very severe cases the possible addition of etoposide, as complement to standard supportive management. The study was published on June 12, 2019, in the journal Clinical Infectious Diseases.
Related Links:
Hospital Sultanah Aminah
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition that comes in primary (genetic) and secondary (acquired) forms. The most common causes of secondary HLH (sHLH) are infections, neoplasms, and autoimmune diseases; the most common infection-associated HLH is caused by Epstein-Barr virus (EBV-HLH).
Medical scientists from Hospital Sultanah Aminah (Johor, Malaysia) working with their Swedish colleagues, carried out a 5-year retrospective single-center study on all adult patients with SD admitted to a tertiary intensive care unit (ICU). The team reported that 39/180 (22%) patients with SD died, and 21/180 (12%) had HLH defined as HLH-probability ≥70% according to HScore; nine (43%) died. Similarly, 12/31 (39%) fulfilling ≥4 and 7/9 (78%) fulfilling ≥5 HLH-2004 diagnostic criteria died.
Peak values of AST, ALT, LDH, and creatinine correlated to fatality (Odds Ratio (OR) =2.9, 3.4, 5.8, and 31.9, respectively), as did peak ferritin (OR=2.5, nadir platelets (OR=1.9); hepatomegaly (OR=2.9), and increasing age (OR=1.2), The median peak AST, ALT, and LDH levels for the 180 patients were 510 U/L (range 22-35,427), 246 U/L (12-8,330), and 1,203 U/L (249-21,591), respectively. Multivariable logistic regression revealed peak AST (OR=2.8), peak creatinine (OR=7.3), and SOFA score (OR=1.4), as independent risk factors of death.
The authors concluded that it is important to be aware of dengue-HLH in SD due to its high mortality. They recommend a prospective study is needed in patients with, or at high risk of developing, dengue-HLH to evaluate prompt HLH-directed therapy with corticosteroids as dexamethasone, and in very severe cases the possible addition of etoposide, as complement to standard supportive management. The study was published on June 12, 2019, in the journal Clinical Infectious Diseases.
Related Links:
Hospital Sultanah Aminah
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Unstirred Waterbath
HumAqua 5
Latest Hematology News
- First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
Channels
Molecular Diagnostics
view channel
Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections
Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more
Non-Biopsy Approach to Transform Adult Celiac Disease Diagnoses
In the United States, the diagnosis of celiac disease in adults typically relies on a combination of serologic testing and a confirmatory small bowel biopsy during upper endoscopy. In contrast, European... Read more
Hematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
New Blood Test Detects Up to Five Infectious Diseases at POC
Researchers have developed a prototype flow-through assay capable of detecting up to five different infections, with results that can be quickly analyzed and transmitted via a specialized smartphone app.... Read more
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
Pathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read more
Technology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
